LeMaitre Vascular Stock Price, News & Analysis (NASDAQ:LMAT)

$34.56 -0.55 (-1.57 %)
(As of 11/18/2017 11:12 AM ET)
Previous Close$34.56
Today's Range$35.11 - $34.38
52-Week Range$19.82 - $39.88
Volume201,445 shs
Average Volume302,333 shs
Market Capitalization$665.8 million
P/E Ratio44.88
Dividend Yield0.64%
Beta0.55

About LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.


Industry, Sector and Symbol:
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: NASDAQ:LMAT
  • CUSIP: N/A
  • Web: www.lemaitre.com
Debt:
  • Current Ratio: 6.25%
  • Quick Ratio: 4.50%
Price-To-Earnings:
  • Trailing P/E Ratio: 44.88
  • Forward P/E Ratio: 41.14
  • P/E Growth: 2.74
Sales & Book Value:
  • Annual Sales: $89.15 million
  • Price / Sales: 7.47
  • Cash Flow: $0.76 per share
  • Price / Cash: 45.29
  • Book Value: $5.51 per share
  • Price / Book: 6.27
Dividend:
  • Annual Dividend: $0.22
  • Dividend Yield: 0.6%
Profitability:
  • Trailing EPS: $0.77
  • Net Income: $10.59 million
  • Net Margins: 15.81%
  • Return on Equity: 16.16%
  • Return on Assets: 14.03%
Misc:
  • Employees: 397
  • Outstanding Shares: 19,260,000
 

Frequently Asked Questions for LeMaitre Vascular (NASDAQ:LMAT)

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular declared a quarterly dividend on Monday, October 30th. Shareholders of record on Wednesday, November 22nd will be given a dividend of $0.055 per share on Thursday, December 7th. This represents a $0.22 annualized dividend and a yield of 0.64%. The ex-dividend date is Tuesday, November 21st. View LeMaitre Vascular's Dividend History.

How will LeMaitre Vascular's stock buyback program work?

LeMaitre Vascular declared that its Board of Directors has authorized a share buyback plan on Friday, July 28th 2017, which allows the company to repurchase $7,500,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to purchase up to 1.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board of directors believes its shares are undervalued.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) issued its quarterly earnings results on Thursday, October, 26th. The medical instruments supplier reported $0.25 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.20 by $0.05. The medical instruments supplier earned $24.80 million during the quarter, compared to analyst estimates of $25.49 million. LeMaitre Vascular had a return on equity of 16.16% and a net margin of 15.81%. LeMaitre Vascular's revenue was up 6.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.17 EPS. View LeMaitre Vascular's Earnings History.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular issued an update on its fourth quarter earnings guidance on Thursday, October, 26th. The company provided earnings per share (EPS) guidance of $0.19-0.21 for the period, compared to the Thomson Reuters consensus estimate of $0.20. The company issued revenue guidance of $25.8-26.6 million, compared to the consensus revenue estimate of $26.58 million.

Where is LeMaitre Vascular's stock going? Where will LeMaitre Vascular's stock price be in 2017?

6 Wall Street analysts have issued twelve-month target prices for LeMaitre Vascular's stock. Their forecasts range from $29.00 to $34.00. On average, they expect LeMaitre Vascular's stock price to reach $31.50 in the next twelve months. View Analyst Ratings for LeMaitre Vascular.

What are Wall Street analysts saying about LeMaitre Vascular stock?

Here are some recent quotes from research analysts about LeMaitre Vascular stock:

  • 1. According to Zacks Investment Research, "LEMAITRE VASCULAR, INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. " (11/10/2017)
  • 2. Canaccord Genuity analysts commented, "We view this event as largely priced in, given the previous success in narcolepsy in a Phase II trial and a successful read-out from two Phase III trials in excessive sleepiness (ES) associated with obstructive sleep apnea (OSA). We currently model an 80% probability of approval and risk-adjusted sales of $558.9 million in 2026." (4/27/2017)

Who are some of LeMaitre Vascular's key competitors?

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the folowing people:

  • George W. LeMaitre, Chairman of the Board, Chief Executive Officer
  • David Brian Roberts, President, Director
  • Joseph P. Pellegrino Jr., Chief Financial Officer, Director
  • Trent G. Kamke, Senior Vice President - Operations
  • Cornelia W. LeMaitre, Vice President - Human Resources
  • Lawrence J. Jasinski, Independent Director
  • John J. O'Connor, Independent Director
  • John A. Roush, Independent Director
  • Michael H. Thomas, Independent Director

Who owns LeMaitre Vascular stock?

LeMaitre Vascular's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.17%), Conestoga Capital Advisors LLC (4.49%), Thomson Horstmann & Bryant Inc. (1.69%), Allianz Asset Management GmbH (1.67%), Bank of New York Mellon Corp (1.13%) and American Century Companies Inc. (1.07%). Company insiders that own LeMaitre Vascular stock include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Joseph P Pellegrino, Jr, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

Who sold LeMaitre Vascular stock? Who is selling LeMaitre Vascular stock?

LeMaitre Vascular's stock was sold by a variety of institutional investors in the last quarter, including Thomson Horstmann & Bryant Inc., Algert Global LLC, Formula Growth Ltd., Alps Advisors Inc., Perkins Capital Management Inc., Bessemer Group Inc., Hillsdale Investment Management Inc. and Strs Ohio. Company insiders that have sold LeMaitre Vascular company stock in the last year include David B Roberts, George W Lemaitre, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

Who bought LeMaitre Vascular stock? Who is buying LeMaitre Vascular stock?

LeMaitre Vascular's stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, 361 Capital LLC, Nationwide Fund Advisors, Janus Henderson Group PLC, Ameriprise Financial Inc., Schwab Charles Investment Management Inc., Rhumbline Advisers and Dimensional Fund Advisors LP. View Insider Buying and Selling for LeMaitre Vascular.

How do I buy LeMaitre Vascular stock?

Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LeMaitre Vascular stock can currently be purchased for approximately $34.56.

How big of a company is LeMaitre Vascular?

LeMaitre Vascular has a market capitalization of $665.8 million and generates $89.15 million in revenue each year. The medical instruments supplier earns $10.59 million in net income (profit) each year or $0.77 on an earnings per share basis. LeMaitre Vascular employs 397 workers across the globe.

How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.


MarketBeat Community Rating for LeMaitre Vascular (NASDAQ LMAT)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  234 (Vote Outperform)
Underperform Votes:  134 (Vote Underperform)
Total Votes:  368
MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for LeMaitre Vascular (NASDAQ:LMAT)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 5 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.17)
Consensus Price Target: $31.50 (8.85% downside)

Consensus Price Target History for LeMaitre Vascular (NASDAQ:LMAT)

Price Target History for LeMaitre Vascular (NASDAQ:LMAT)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/29/2017Stifel NicolausReiterated RatingBuyN/AView Rating Details
10/27/2017Canaccord GenuityLower Price TargetHold$30.00 -> $29.00N/AView Rating Details
10/27/2017Benchmark Co.DowngradeBuy -> HoldN/AView Rating Details
10/27/2017First AnalysisDowngradeOverweight -> Equal Weight$34.00N/AView Rating Details
6/6/2017Craig HallumInitiated CoverageHold$31.00LowView Rating Details
2/22/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
9/22/2016SidotiDowngradeBuy -> Neutral$23.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50N/AView Rating Details
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00N/AView Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for LeMaitre Vascular (NASDAQ:LMAT)

Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Earnings History by Quarter for LeMaitre Vascular (NASDAQ LMAT)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017Q3 2017$0.20$0.25$25.49 million$24.80 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.17$0.23$25.42 million$25.80 millionViewN/AView Earnings Details
5/4/2017Q1 2017$0.13$0.16$23.48 million$24.10 millionViewN/AView Earnings Details
2/21/2017Q4 2016$0.15$0.13$23.70 million$23.30 millionViewListenView Earnings Details
10/26/2016Q3$0.15$0.17$22.20 million$19.00 millionViewListenView Earnings Details
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11$20.22 million$20.26 millionViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.08$0.11$18.78 million$19.03 millionViewListenView Earnings Details
7/28/2015Q2$0.07$0.10$18.90 million$19.90 millionViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05$17.09 million$17.50 millionViewListenView Earnings Details
2/25/2014Q4$0.05$0.05ViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)
2017 EPS Consensus Estimate: $0.67
2018 EPS Consensus Estimate: $0.92
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.13$0.14$0.13
Q2 20173$0.17$0.17$0.17
Q3 20173$0.17$0.20$0.18
Q4 20173$0.18$0.19$0.19
Q1 20182$0.19$0.20$0.20
Q2 20182$0.22$0.25$0.24
Q3 20182$0.21$0.24$0.23
Q4 20181$0.26$0.26$0.26
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for LeMaitre Vascular (NASDAQ:LMAT)

Next Dividend:12/7/2017
Annual Dividend:$0.22
Dividend Yield:0.64%
Payout Ratio:28.57% (Trailing 12 Months of Earnings)
26.19% (Based on This Year's Estimates)
25.29% (Based on Next Year's Estimates)
Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Dividend History by Quarter for LeMaitre Vascular (NASDAQ LMAT)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/30/2017quarterly$0.060.71%11/21/201711/22/201712/7/2017
7/28/2017quarterly$0.060.64%8/21/20178/23/20179/7/2017
4/28/2017quarterly$0.060.74%5/22/20175/24/20176/8/2017
2/23/2017quarterly$0.061%3/20/20173/22/20174/6/2017
10/27/2016quarterly$0.050.85%11/17/201611/21/201612/5/2016
7/29/2016quarterly$0.051.05%8/18/20168/22/20169/6/2016
5/4/2016quarterly$0.051.12%5/23/20165/25/20166/8/2016
2/25/2016quarterly$0.051.19%3/17/20163/21/20164/4/2016
10/29/2015quarterly$0.041.11%11/18/201511/20/201512/4/2015
7/29/2015quarterly$0.041.25%8/18/20158/20/20159/3/2015
4/29/2015quarterly$0.041.85%5/20/20155/22/20156/5/2015
2/26/2015quarterly$0.042.03%3/18/20153/20/20154/3/2015
10/28/2014quarterly$0.041.93%11/18/201411/20/201412/4/2014
7/31/2014quarterly$0.041.73%8/19/20148/21/20149/4/2014
4/30/2014quarterly$0.041.71%5/20/20145/22/20146/5/2014
2/26/2014quarterly$0.041.75%3/18/20143/20/20144/3/2014
10/31/2013quarterly$0.031.49%11/18/201311/20/201312/4/2013
7/30/2013quarterly$0.031.73%8/19/20138/21/20139/4/2013
5/2/2013quarterly$0.031.98%5/20/20135/22/20136/5/2013
2/27/2013quarterly$0.031.92%3/18/20133/20/20134/3/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for LeMaitre Vascular (NASDAQ LMAT)

Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 68.50%
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Insider Trades by Quarter for LeMaitre Vascular (NASDAQ LMAT)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2017David B RobertsInsiderSell4,123$32.14$132,513.22View SEC Filing  
8/30/2017David B RobertsInsiderSell26,683$36.67$978,465.61View SEC Filing  
8/30/2017George W LemaitreCEOSell15,000$37.13$556,950.00View SEC Filing  
8/29/2017George W LemaitreCEOSell15,000$36.72$550,800.00View SEC Filing  
8/28/2017George W LemaitreCEOSell30,000$36.43$1,092,900.00View SEC Filing  
8/25/2017George W LemaitreChairmanSell40,000$33.89$1,355,600.00View SEC Filing  
8/24/2017George W LemaitreCEOSell15,000$33.97$509,550.00View SEC Filing  
8/23/2017George W LemaitreCEOSell5,000$33.91$169,550.00View SEC Filing  
8/17/2017Lawrence J JasinskiDirectorSell2,030$34.23$69,486.90View SEC Filing  
8/11/2017George W LemaitreChairmanSell21,300$32.90$700,770.00View SEC Filing  
8/10/2017George W LemaitreCEOSell11,300$32.79$370,527.00View SEC Filing  
8/9/2017George W LemaitreChairmanSell30,000$33.65$1,009,500.00View SEC Filing  
8/8/2017George W LemaitreCEOSell10,000$34.02$340,200.00View SEC Filing  
8/7/2017George W LemaitreCEOSell10,000$33.62$336,200.00View SEC Filing  
8/7/2017Peter R GebauerInsiderSell6,224$33.85$210,682.40View SEC Filing  
8/4/2017David B RobertsInsiderSell48,317$33.12$1,600,259.04View SEC Filing  
8/3/2017George W LemaitreChairmanSell58,700$33.97$1,994,039.00View SEC Filing  
8/3/2017Peter R GebauerInsiderSell22,067$34.28$756,456.76View SEC Filing  
8/1/2017Lawrence J JasinskiDirectorSell6,500$34.47$224,055.00View SEC Filing  
6/1/2017Michael T WijasVPSell2,346$31.42$73,711.32View SEC Filing  
5/24/2017Trent G KamkeInsiderSell15,780$30.28$477,818.40View SEC Filing  
5/18/2017George W LemaitreChairmanSell21,225$30.11$639,084.75View SEC Filing  
5/11/2017David B RobertsInsiderSell39,531$30.37$1,200,556.47View SEC Filing  
5/10/2017George W LemaitreChairmanSell63,622$30.98$1,971,009.56View SEC Filing  
5/9/2017George W LemaitreCEOSell34,517$30.67$1,058,636.39View SEC Filing  
5/8/2017George W LemaitreCEOSell9,102$31.12$283,254.24View SEC Filing  
5/4/2017David B RobertsInsiderSell44,340$31.14$1,380,747.60View SEC Filing  
5/3/2017George W LemaitreChairmanSell87,342$32.35$2,825,513.70View SEC Filing  
3/10/2017David B RobertsInsiderSell5,900$22.44$132,396.00View SEC Filing  
3/1/2017George W LemaitreChairmanSell10,000$22.36$223,600.00View SEC Filing  
2/28/2017George W LemaitreCEOSell3,000$22.27$66,810.00View SEC Filing  
2/27/2017George W LemaitreCEOSell5,000$22.31$111,550.00View SEC Filing  
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.60View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.68View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.00View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.10View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.20View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.70View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.00View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.52View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.53View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.88View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.60View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.00View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.00View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.00View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.89View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.00View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.00View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.60View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.76View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.00View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.80View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.00View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.30View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.12View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.00View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.60View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.95View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.13View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.70View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.48View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.32View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.76View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.01View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.00View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.00View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.00View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.20View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.80View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.00View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.50View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.55View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.31View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.67View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.64View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.85View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.00View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.34View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.28View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.04View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for LeMaitre Vascular (NASDAQ LMAT)

Source:
DateHeadline
Validea Motley Fool Strategy Daily Upgrade Report - 11/18/2017 - NasdaqValidea Motley Fool Strategy Daily Upgrade Report - 11/18/2017 - Nasdaq
www.nasdaq.com - November 19 at 12:36 AM
LeMaitre Vascular About To Put More Money In Your Pocket (LMAT)LeMaitre Vascular About To Put More Money In Your Pocket (LMAT)
www.thestreet.com - November 18 at 4:26 AM
Should You Buy LeMaitre Vascular Inc (LMAT) Now?Should You Buy LeMaitre Vascular Inc (LMAT) Now?
finance.yahoo.com - November 17 at 8:17 AM
3 Unknown, but Amazing, Dividend Stocks3 Unknown, but Amazing, Dividend Stocks
finance.yahoo.com - November 16 at 10:12 AM
LeMaitre Vascular Reaches Analyst Target PriceLeMaitre Vascular Reaches Analyst Target Price
www.thestreet.com - November 11 at 5:02 PM
David B. Roberts Sells 4,123 Shares of LeMaitre Vascular, Inc. (LMAT) StockDavid B. Roberts Sells 4,123 Shares of LeMaitre Vascular, Inc. (LMAT) Stock
www.americanbankingnews.com - November 7 at 7:10 PM
Analyzing LeMaitre Vascular (LMAT) and Its PeersAnalyzing LeMaitre Vascular (LMAT) and Its Peers
www.americanbankingnews.com - November 7 at 5:34 AM
LeMaitre Vascular, Inc. Expected to Post Q1 2018 Earnings of $0.20 Per Share (LMAT)LeMaitre Vascular, Inc. Expected to Post Q1 2018 Earnings of $0.20 Per Share (LMAT)
www.americanbankingnews.com - November 2 at 1:02 PM
LeMaitre Vascular, Inc. (LMAT) Expected to Announce Quarterly Sales of $26.29 MillionLeMaitre Vascular, Inc. (LMAT) Expected to Announce Quarterly Sales of $26.29 Million
www.americanbankingnews.com - November 2 at 9:10 AM
LeMaitre Vascular to Present at Upcoming November and December Investor ConferencesLeMaitre Vascular to Present at Upcoming November and December Investor Conferences
finance.yahoo.com - November 2 at 5:43 AM
LeMaitre Vascular, Inc. (LMAT) Cut to Hold at Zacks Investment ResearchLeMaitre Vascular, Inc. (LMAT) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - November 2 at 12:56 AM
LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : October 31, 2017LeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : October 31, 2017
finance.yahoo.com - November 1 at 5:27 AM
LeMaitre Vascular (LMAT) & Its Peers Head-To-Head SurveyLeMaitre Vascular (LMAT) & Its Peers Head-To-Head Survey
www.americanbankingnews.com - October 31 at 3:20 AM
LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 30, 2017
finance.yahoo.com - October 31 at 1:12 AM
ETFs with exposure to LeMaitre Vascular, Inc. : October 30, 2017ETFs with exposure to LeMaitre Vascular, Inc. : October 30, 2017
finance.yahoo.com - October 31 at 1:12 AM
LeMaitre Vascular, Inc. (LMAT) Plans Quarterly Dividend of $0.06LeMaitre Vascular, Inc. (LMAT) Plans Quarterly Dividend of $0.06
www.americanbankingnews.com - October 30 at 6:24 PM
LeMaitre Vascular, Inc. (LMAT) to Post FY2017 Earnings of $0.84 Per Share, Barrington Research ForecastsLeMaitre Vascular, Inc. (LMAT) to Post FY2017 Earnings of $0.84 Per Share, Barrington Research Forecasts
www.americanbankingnews.com - October 30 at 3:24 AM
LeMaitre Vascular Is Now Oversold (LMAT)LeMaitre Vascular Is Now Oversold (LMAT)
www.thestreet.com - October 29 at 7:20 PM
YieldBoost LeMaitre Vascular To 6% Using OptionsYieldBoost LeMaitre Vascular To 6% Using Options
www.thestreet.com - October 28 at 7:46 AM
Edited Transcript of LMAT earnings conference call or presentation 26-Oct-17 9:00pm GMTEdited Transcript of LMAT earnings conference call or presentation 26-Oct-17 9:00pm GMT
finance.yahoo.com - October 28 at 7:46 AM
LeMaitre Vascular, Inc. (LMAT) PT Lowered to $29.00LeMaitre Vascular, Inc. (LMAT) PT Lowered to $29.00
www.americanbankingnews.com - October 27 at 6:20 PM
LeMaitre Vascular, Inc. (LMAT) Receives Average Recommendation of "Hold" from AnalystsLeMaitre Vascular, Inc. (LMAT) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 27 at 1:30 AM
LeMaitre beats 3Q profit forecastsLeMaitre beats 3Q profit forecasts
finance.yahoo.com - October 26 at 11:20 PM
LeMaitre Vascular, Inc. (LMAT) Issues  Earnings Results, Beats Estimates By $0.05 EPSLeMaitre Vascular, Inc. (LMAT) Issues Earnings Results, Beats Estimates By $0.05 EPS
www.americanbankingnews.com - October 26 at 10:56 PM
LeMaitre Vascular, Inc. (LMAT) Issues Q4 Earnings GuidanceLeMaitre Vascular, Inc. (LMAT) Issues Q4 Earnings Guidance
www.americanbankingnews.com - October 26 at 6:03 PM
LeMaitre Vascular, Inc. to Host Earnings CallLeMaitre Vascular, Inc. to Host Earnings Call
finance.yahoo.com - October 26 at 5:54 PM
LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)
finance.yahoo.com - October 26 at 5:54 PM
Critical Analysis: EDAP TMS (EDAP) and LeMaitre Vascular (LMAT)Critical Analysis: EDAP TMS (EDAP) and LeMaitre Vascular (LMAT)
www.americanbankingnews.com - October 24 at 4:38 PM
LeMaitre Vascular (LMAT) & Its Competitors Head to Head AnalysisLeMaitre Vascular (LMAT) & Its Competitors Head to Head Analysis
www.americanbankingnews.com - October 21 at 8:15 AM
Financial Analysis: LeMaitre Vascular (LMAT) vs. Its RivalsFinancial Analysis: LeMaitre Vascular (LMAT) vs. Its Rivals
www.americanbankingnews.com - October 18 at 6:36 AM
LeMaitre Vascular (LMAT) versus The Competition Critical ReviewLeMaitre Vascular (LMAT) versus The Competition Critical Review
www.americanbankingnews.com - October 17 at 12:54 PM
LeMaitre Vascular, Inc. (LMAT) Scheduled to Post Earnings on TuesdayLeMaitre Vascular, Inc. (LMAT) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - October 17 at 6:26 AM
LeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017 - NasdaqLeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017 - Nasdaq
www.nasdaq.com - October 17 at 1:01 AM
LeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017LeMaitre Vascular Will Announce Third Quarter 2017 Earnings Results on October 26, 2017
finance.yahoo.com - October 16 at 7:59 PM
LeMaitre Vascular, Inc. (LMAT) Expected to Announce Quarterly Sales of $25.42 MillionLeMaitre Vascular, Inc. (LMAT) Expected to Announce Quarterly Sales of $25.42 Million
www.americanbankingnews.com - October 14 at 5:46 AM
LeMaitre Vascular (LMAT) & Fulgent Genetic (FLGT) Head to Head AnalysisLeMaitre Vascular (LMAT) & Fulgent Genetic (FLGT) Head to Head Analysis
www.americanbankingnews.com - October 14 at 2:20 AM
LeMaitre Vascular, Inc. (LMAT) Sees Large Increase in Short InterestLeMaitre Vascular, Inc. (LMAT) Sees Large Increase in Short Interest
www.americanbankingnews.com - October 14 at 1:40 AM
$0.20 EPS Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter$0.20 EPS Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - October 12 at 12:26 PM
LeMaitre Vasculars (LMAT) Hold Rating Reiterated at Canaccord GenuityLeMaitre Vascular's (LMAT) Hold Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - October 9 at 6:55 AM
Stocks With Rising Relative Strength: PenumbraStocks With Rising Relative Strength: Penumbra
finance.yahoo.com - October 2 at 12:22 PM
ETFs with exposure to LeMaitre Vascular, Inc. : September 28, 2017ETFs with exposure to LeMaitre Vascular, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 12:21 PM
LeMaitre Vascular, Inc. (LMAT) Given Consensus Recommendation of "Hold" by BrokeragesLeMaitre Vascular, Inc. (LMAT) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 1 at 11:14 PM
Reviewing LeMaitre Vascular (LMAT) and Luna Innovations (LUNA)Reviewing LeMaitre Vascular (LMAT) and Luna Innovations (LUNA)
www.americanbankingnews.com - September 28 at 4:30 AM
$25.42 Million in Sales Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter$25.42 Million in Sales Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - September 25 at 3:02 AM
5 MedTech Stocks to Pick for Stellar Returns - Nasdaq5 MedTech Stocks to Pick for Stellar Returns - Nasdaq
www.nasdaq.com - September 19 at 1:01 AM
ETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2017ETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2017
finance.yahoo.com - September 15 at 6:06 AM
LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
finance.yahoo.com - September 14 at 7:15 AM
 Brokerages Anticipate LeMaitre Vascular, Inc. (LMAT) Will Post Quarterly Sales of $25.42 Million Brokerages Anticipate LeMaitre Vascular, Inc. (LMAT) Will Post Quarterly Sales of $25.42 Million
www.americanbankingnews.com - September 7 at 11:30 AM
LeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Hold" by BrokeragesLeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 6 at 10:42 PM
Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead - NasdaqForget Abbott, Buy These 4 High-Growth MedTech Stocks Instead - Nasdaq
www.nasdaq.com - September 6 at 9:43 PM

Social Media

Financials

Chart

LeMaitre Vascular (NASDAQ LMAT) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.